Pituitary Preceptorship: How do I decide when to discontinue cabergoline therapy in prolactinomas

Dr Vila is Associate Professor of Medicine at the Medical University of Vienna, Austria. She graduated at the University of Tirana, Albania, and obtained her doctor’s degree at the Ludwig Maximilian University of Munich, Germany in 2004 with a translational thesis on the role of Sonic hedgehog signaling on corticotroph function and pituitary adenomas. She previously worked in the Division of Endocrinology, Hospital Saint-Antoine, Paris (2000-2001) and the Neuroendocrinology Group of the Max-Planck-Institute of Psychiatry in Munich (2002-2005), before joining the Division of Endocrinology at the Vienna General Hospital in 2006. Her primary clinical and research interests are pituitary diseases, and in particular neuroendocrine-metabolic interactions.